This site is intended for healthcare professionals only
LoginRegister
Kerala Government Medical College StrikeJJ Hospital Resident Doctors allege academic irregularities at Ophthalmology Dept, begin Strike...
It would be a sheer waste of medical education: HC Allows Three Students to Keep BDS Degrees Despite Irregular AdmissionHigh Court seeks status report of Nainital district hospital
Dr Reddys Prepares Generic Semaglutide Entry Under Brand Obeda, Targets 60% Price Cut: ReportDr. Reddy's Gets CDSCO Panel Nod to study gastric acid blocker Vonoprazan fumarate
AstraZeneca Pharma India names Bhavana Agrawal as new CFOAstraZeneca Pharma India names Bhavana Agrawal as new CFO
After NMC halts fresh MBBS admissions, BFUHS cancels affiliation of Chintpurni Medical CollegeAfter NMC halts fresh MBBS admissions, BFUHS cancels affiliation of Chintpurni Medical College
NMC Revokes Recognition of FCIMS Warangal Following Bribery Allegations Against TrusteeNMC cancels recognition of three medical colleges in Assam
PG Medicos can Appear in Final Exams without Completing Online Course in Research Methods: NMCPG Medicos can Appear in Final Exams without Completing Online Course in Research Methods: NMC
CENTAC invites applications for NEET PG, NEET MDS counselling 2023, Check out registration process, eligibility criteria, all details hereCENTAC invites applications for NEET PG, NEET MDS counselling 2023, Check out registration process,...
Natco Pharma gets 7 USFDA observations for Kothur Pharma DivisionUSFDA inspection: Caplin Steriles gets 4 observations for Gummidipoondi site
Haryana govt orders Live CCTV monitoring of ICUs for Ayushman Bharat patients, doctors flag privacy concerns5 Crore hospital admissions authorized under Ayushman Bharat Pradhan Mantri Jan Arogya Yojana
CDSCO Panel Approves Phase IV Protocol Amendment for Bristol-Myers Squibbs Mavacamten StudyBristol Myers Squibb gets USFDA priority review for lung cancer treatment Repotrectinib
Laurus Labs to buy additional stake of 7.24 percent in Immunoadoptive Cell Therapy for Rs 80 CroreLaurus Labs to buy additional stake of 7.24 percent in Immunoadoptive Cell Therapy for Rs 80 Crore
X